Kolexia
Lippert Eric
Biologie médicale
Hôpital Cavale Blanche
Brest, France
165 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Thrombocytose Thrombocytémie essentielle Syndromes myéloprolifératifs Polyglobulie Polyglobulie primitive essentielle Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Thrombose

Industries

Novartis
8 collaboration(s)
Dernière en 2021
Abbvie
2 collaboration(s)
Dernière en 2021
Incyte
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
American journal of hematology   25 février 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
CLOJAK: Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)
Essai Clinique (CHU Bordeaux)   09 novembre 2023
Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
European journal of haematology   30 octobre 2023
BioScoreSMP: Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis
Essai Clinique (CHU Angers)   21 septembre 2023
Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
Thrombosis research   14 juin 2023
Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis.
Thrombosis research   28 avril 2023
Differences between aquagenic and non-aquagenic pruritus in myeloproliferative neoplasms: An observational study of 500 patients.
Journal of the European Academy of Dermatology and Venereology : JEADV   09 mars 2023
101 Aquagenic and non-aquagenic pruritus need to be differentiated in MPN: A study of 500 patients
ESDR 2022 Meeting Abstract Supplement   01 décembre 2022